This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.
1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.
Learn more in this exclusive article. Cobenfy failed to meet the primary endpoint in a phase 3 trial for schizophrenia, but showed numerical improvement, warranting further investigation. SHOW MORE What disease states are most prominently featured in recent research?
Unbalanced, for instance, in the sense that much emphasis is placed on brain and genetic studies that to this day have cost billions of dollars, while showing only very small associations—not providing any basis for biological screening. Genetic studies are also the cause of many misunderstandings.
A recent Neuroscience News article is titled “ Bipolardisorder can be detected with blood test. ” 1 This is one of many recent, oversimplified headlines that encourage us to think we are on the brink of discovering the next biomarker that will scientifically validate biomedical psychiatric disorders.
Schizophrenia is a serious mentalhealth condition that can cause people to lose touch with reality and see, hear, or believe things that arent real or true. Schizophrenia is a mentalhealthdisorder that affects an individuals ability to distinguish reality from fantasy. What is schizophrenia?
per cent of the population have schizoaffective disorder: its a lot less common than either major depression or bipolardisorder. Individuals with schizophrenia may have an increased risk for first-degree relatives for schizoaffective disorder, and vice-versa. What Causes Schizoaffective Disorder?
Research shows women develop substance dependencies faster than men and experience more severe health consequences from prolonged substance use. Addressing MentalHealth in Women’s Recovery Journey Mentalhealth care plays a vital role in women’s addiction recovery.
T he decades-long attempt to locate the gene or genes for schizophrenia has failed, according to a new article in Psychiatric Research by prominent schizophrenia researcher E. Torrey is a psychiatrist and a researcher on schizophrenia and bipolardisorder. Fuller Torrey. Fuller Torrey?
However, mentaldisorders are not concrete things that can be found with a brain scanner or treated with medication like a bacterial infection with antibiotics. Much has already been written about these points, for example in my book on mentalhealth and substance use (open access).
Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.
Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S.
Thomas Insel, director of the National Institute of MentalHealth (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mentalhealth is getting worse by multiple metrics. As of late 2022, just 31% of U.S.
667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.
E xuberant individuals who disregard societal consensus reality are routinely diagnosed by psychiatrists with bipolardisorder; however, among psychiatrists themselves, exuberance about psychiatry regardless of the reality of psychiatry’s repeated scientific failures makes one a leading psychiatrist. Thomas Insel, quoted in 2017. “To
Image courtesy of Pixabay.com How do you know if you have ADHD (Attention-Deficit Hyperactivity Disorder) ? This is the second in a series of articles on recognizing ADHD in yourself as an adult, its main causes, proper diagnosis, and suggestions regarding how to address it. What makes this condition recognizable for an adult?
Editor’s Note: This article originally appeared on Mad in Italy. Premise In our information we always emphasize that psychotropic drugs do not have a specific action on mental problems or psychopathology, but only on their symptoms. She has a degree in biological sciences and a PhD in pharmacology from the University of Ferrara.
Depression is a mentalhealthdisorder that affects roughly 10 to 15 percent of the general population. In most cases depressed lawyers, like most depressed individuals, have a genetic predisposition to the disorder. Take your mentalhealth seriously. and the Commonwealth of Virginia.
April 16, 2025 Every few years, the ADHD community must endure another skeptic an author, a journalist, a contrarian mentalhealth provider, quite frequently a chiropractor recycling claims like “ADHD is overdiagnosed,” “stimulants dont work,” or, most remarkably in one case, “ADHD does not exist.”
April 16, 2025 Since its publication last Sunday, The New York Times Magazine article “Have We Been Thinking About ADHD All Wrong?” To be clear, identifiable biomarkers do not yet exist for many psychiatric, neurodevelopmental, and neurodegenerative disorders. Or bipolardisorder?” Or anxiety?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content